Centene has announced a collaboration with Quest Diagnostics to increase access to real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in critical areas of need across the country. Through this collaboration, Centene will facilitate the distribution of 25,000 Quest COVID-19 test kits each week to Federally Qualified Health Centers (FQHCs) in 10 states or districts across the country.
This collaboration leverages Centene's extensive network of critical safety net providers to ensure that testing capacity is routed to where it is needed most. As part of the collaboration, Centene will provide oversight and training to ensure test kits are received and processed efficiently. Distribution of kits began May 4th, and Quest Diagnostics will conduct the COVID-19 testing through its network of laboratories across the United States.
This initiative is part of a broader set of actions that Centene is taking with key providers and stakeholders across the country to support safety net providers in addressing the pandemic.
